|
|
Volumn 12, Issue 12, 2015, Pages 705-717
|
|
Post-transplantation malignancies: Here today, gone tomorrow?
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALEMTUZUMAB;
BASILIXIMAB;
CALCINEURIN;
CYCLOSPORIN;
CYTOTOXIC T LYMPHOCYTE ANTIGEN 4;
DACLIZUMAB;
HLA A11 ANTIGEN;
HLA B27 ANTIGEN;
HLA DR7 ANTIGEN;
INTERLEUKIN 2;
MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1;
MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 2;
MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR;
MYCOPHENOLATE MOFETIL;
PROGRAMMED DEATH 1 RECEPTOR;
TOFACITINIB;
IMMUNOSUPPRESSIVE AGENT;
BREAST CANCER;
CANCER INCIDENCE;
CANCER INHIBITION;
CANCER RISK;
CANCER SUSCEPTIBILITY;
EPSTEIN BARR VIRUS;
GRAFT RECIPIENT;
HEPATITIS B VIRUS;
HEPATITIS C;
HEPATITIS C VIRUS;
HUMAN;
HUMAN HERPESVIRUS 8;
IMMUNOLOGICAL TOLERANCE;
IMMUNOSUPPRESSIVE TREATMENT;
KAPOSI SARCOMA;
LIP CANCER;
LIVER CELL CARCINOMA;
MALIGNANT NEOPLASTIC DISEASE;
MELANOMA;
MERKEL CELL POLYOMAVIRUS;
MERKEL CELL TUMOR;
NON MELANOMA SKIN CANCER;
NONHODGKIN LYMPHOMA;
NONHUMAN;
POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE;
POSTTRANSPLANT MALIGNANCY;
PRIORITY JOURNAL;
PROSTATE CANCER;
PROTEIN EXPRESSION;
PROTEIN FUNCTION;
REVIEW;
RISK ASSESSMENT;
SKIN CANCER;
WART VIRUS;
CHEMICALLY INDUCED;
NEOPLASM;
ORGAN TRANSPLANTATION;
POSTOPERATIVE COMPLICATION;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
NEOPLASMS;
ORGAN TRANSPLANTATION;
POSTOPERATIVE COMPLICATIONS;
|
|
EID: 84948383598
PISSN: 17594774
EISSN: 17594782
Source Type: Journal
DOI: 10.1038/nrclinonc.2015.186 Document Type: Review |
|
Times cited : (52)
|
|
References (0)
|
